These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 22445386

  • 1. Synthesis and comparative assessment of a labeled RGD peptide bearing two different ⁹⁹mTc-tricarbonyl chelators for potential use as targeted radiopharmaceutical.
    Psimadas D, Fani M, Gourni E, Loudos G, Xanthopoulos S, Zikos C, Bouziotis P, Varvarigou AD.
    Bioorg Med Chem; 2012 Apr 15; 20(8):2549-57. PubMed ID: 22445386
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, characterization, and biological evaluation of (99m) Tc(CO)3 -labeled peptides for potential use as tumor targeted radiopharmaceuticals.
    Baishya R, Nayak DK, Chatterjee N, Halder KK, Karmakar S, Debnath MC.
    Chem Biol Drug Des; 2014 Jan 15; 83(1):58-70. PubMed ID: 23679852
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and comparative in vivo evaluation of 99m Tc(CO)3 -labeled PEGylated and non-PEGylated cRGDfK peptide monomers.
    Vats K, Satpati D, Sharma R, Sarma HD, Banerjee S.
    Chem Biol Drug Des; 2017 Mar 15; 89(3):371-378. PubMed ID: 27561428
    [Abstract] [Full Text] [Related]

  • 4. Exploring the Potential of (99m)Tc(CO)3-Labeled Triazolyl Peptides for Tumor Diagnosis.
    Gaonkar RH, Ganguly S, Baishya R, Dewanjee S, Sinha S, Gupta A, Ganguly S, Debnath MC.
    Cancer Biother Radiopharm; 2016 Apr 15; 31(3):110-7. PubMed ID: 27093344
    [Abstract] [Full Text] [Related]

  • 5. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
    Zhang X, Chen X.
    Appl Radiat Isot; 2007 Jan 15; 65(1):70-8. PubMed ID: 17011200
    [Abstract] [Full Text] [Related]

  • 6. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov 15; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 7. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr 15; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 8. A novel concept of radiosynthesis of a (99m)Tc-labeled dimeric RGD peptide as a potential radiotracer for tumor imaging.
    Mittal S, Bhadwal M, Chakraborty S, Sarma HD, Banerjee S, Pillai MR.
    Bioorg Med Chem Lett; 2013 Mar 15; 23(6):1808-12. PubMed ID: 23414841
    [Abstract] [Full Text] [Related]

  • 9. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
    Ocampo-García BE, Santos-Cuevas CL, De León-Rodríguez LM, García-Becerra R, Ordaz-Rosado D, Luna-Guitiérrez MA, Jiménez-Mancilla NP, Romero-Piña ME, Ferro-Flores G.
    Nucl Med Biol; 2013 May 15; 40(4):481-7. PubMed ID: 23618768
    [Abstract] [Full Text] [Related]

  • 10. Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agent.
    Tsiapa I, Loudos G, Varvarigou A, Fragogeorgi E, Psimadas D, Tsotakos T, Xanthopoulos S, Mihailidis D, Bouziotis P, Nikiforidis GC, Kagadis GC.
    Nucl Med Biol; 2013 Feb 15; 40(2):262-72. PubMed ID: 23238128
    [Abstract] [Full Text] [Related]

  • 11. Study of the labeling of two novel RGD-peptidic derivatives with the precursor [99mTc(H2O)3(CO)3]+ and evaluation for early angiogenesis detection in cancer.
    Psimadas D, Fani M, Zikos C, Xanthopoulos S, Archimandritis SC, Varvarigou AD.
    Appl Radiat Isot; 2006 Feb 15; 64(2):151-9. PubMed ID: 16099668
    [Abstract] [Full Text] [Related]

  • 12. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA, Cescato R, Ketani E, Waser B, Reubi JC, Maina T.
    J Med Chem; 2012 Oct 11; 55(19):8364-74. PubMed ID: 22966957
    [Abstract] [Full Text] [Related]

  • 13. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with 99mTc(I) Tricarbonyl Complex.
    Ku A, Chan C, Aghevlian S, Cai Z, Cescon D, Bratman SV, Ailles L, Hedley DW, Reilly RM.
    Mol Pharm; 2019 Aug 05; 16(8):3559-3568. PubMed ID: 31242384
    [Abstract] [Full Text] [Related]

  • 14. Imaging of HER2-Positive Tumors in NOD/SCID Mice with Pertuzumab Fab-Hexahistidine Peptide Immunoconjugates Labeled with [99mTc]-(I)-Tricarbonyl Complex.
    Facca VJ, Al-Saden N, Ku A, Reilly RM.
    Mol Imaging Biol; 2021 Aug 05; 23(4):495-504. PubMed ID: 33479914
    [Abstract] [Full Text] [Related]

  • 15. Novel 99mTc '4 + 1' peptide conjugates: tuning the biodistribution by variation of coligands.
    Kunstler JU, Seidel G, Bergmann R, Gniazdowska E, Walther M, Schiller E, Decristoforo C, Stephan H, Haubner R, Steinbach J, Pietzsch HJ.
    Eur J Med Chem; 2010 Sep 05; 45(9):3645-55. PubMed ID: 20570022
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of 99mTc-labeled cyclic RGD dimers: impact of cyclic RGD peptides and 99mTc chelates on biological properties.
    Zhou Y, Kim YS, Lu X, Liu S.
    Bioconjug Chem; 2012 Mar 21; 23(3):586-95. PubMed ID: 22369387
    [Abstract] [Full Text] [Related]

  • 17. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, Bading JR, Laug WE, Conti PS.
    J Nucl Med; 2004 Oct 21; 45(10):1776-83. PubMed ID: 15471848
    [Abstract] [Full Text] [Related]

  • 18. Tetraamine-derived bifunctional chelators for technetium-99m labelling: synthesis, bioconjugation and evaluation as targeted SPECT imaging probes for GRP-receptor-positive tumours.
    Abiraj K, Mansi R, Tamma ML, Forrer F, Cescato R, Reubi JC, Akyel KG, Maecke HR.
    Chemistry; 2010 Feb 15; 16(7):2115-24. PubMed ID: 20066690
    [Abstract] [Full Text] [Related]

  • 19. Effect of coligands on biodistribution characteristics of ternary ligand 99mTc complexes of a HYNIC-conjugated cyclic RGDfK dimer.
    Liu S, Hsieh WY, Kim YS, Mohammed SI.
    Bioconjug Chem; 2005 Feb 15; 16(6):1580-8. PubMed ID: 16287258
    [Abstract] [Full Text] [Related]

  • 20. Tc-99m Glu-Cys-Gly-His-Gly-Lys (ECG-HGK), a novel Tc-99m labeled hexapeptide for molecular tumor imaging.
    Kim DW, Kim MH, Kim CG.
    J Labelled Comp Radiopharm; 2016 Mar 15; 59(3):124-8. PubMed ID: 26856188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.